Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

HALF-YEAR REPORT Period from January 2021 to June 2021

Lune Group OY incl subsidiary is consolidated in the group from 2020-06-03  Peptonic Medical AB (publ) org nr 556776-3064(www.aktietorget.se ticker: PMED) Group, Lune Group OY incl subsidiary is included from 2020-06-03 2021 SECOND QUARTER (Apr-Jun) · Net sales of products KSEK 7 356 (3 572) · Gross profit KSEK 4 863 (2 417), Gross margin 66% (68%) · Operating loss KSEK -12 271 (-7 166)  · Loss per share SEK -0.06 (-0.05) 2021 FIRST HALF YEAR (Jan-Jun) · Net sales of products KSEK 18 747 (5 353) · Gross profit KSEK 11 439 (3 402), Gross margin 61% (64%) ·

iioote welcomes Morgan Sjöberg as Senior IoT Advisor!

Morgan Sjöberg further strengthens the iioote team with solid IT and IoT/LPWAN expertise. He joins from Uddevalla Energi AB, where he served 23 years as IT manager as well as responsible for the built up the company's LoRaWAN IoT network. Morgan will primarily work as an expert advisor and with complex IoT projects. iioote are independent IoT specialists who assists companies, municipalities and organizations to choose the right IoT technology and solutions including sensors, access to IoT networks and applications for presentation and smart use of data. iioote has an agnostic

Diamyd Medical strengthens presence at scientific conferences

Diamyd Medical, represented by CEO Ulf Hannelius, has been elected to present a scientific poster at the American Society of Human Genetics (ASHG) conference to be held as a digital event on October 18 to October 22, 2021. The poster details the design of a pivotal genetic precision medicine trial based on findings from a large-scale meta-analysis encompassing more than 600 individuals with type 1 diabetes that have participated in clinical trials with the diabetes vaccine Diamyd[®] (GAD-alum).“There is a notably increasing interest from the scientifc community regarding our genetic

Kamux continues its international expansion — showroom no. 22 in Sweden to be opened in Malmö

Kamux Corporation       Press Release               August 18, 2021 at 9:45 (EEST) Kamux continues its international expansion — showroom no. 22 in Sweden to be opened in Malmö Kamux continues to expand and internationalize by opening a showroom in Malmö in Sweden in the second quarter of 2022. “In line with its strategy, Kamux is striving for strong growth. Before summer, we opened the Gothenburg megastore that is four times the size of an average store. In July, we launched a car processing center on the same premises. Malmö is the third largest city in Sweden, and with the

Upcoming events in the fall from 2cureX

2cureX is progressing into an important phase of the company’s development with key milestones being achieved for positioning IndiTreat products internationally. We would like to keep our shareholders, customers and media updated on the company’s progress with a number of communication events in the coming fall.Upcoming events | 2cureX  Please save the dates and join us.   2021-08-26 Q2 Interim Report released2021-08-27 Webinar: Presentation of the Q2 report by CEO Fernando Andreu,at 14:00 CFO Kenneth G. Johansen and CSO Ole

Lumito AB publishes Quarterly Report 2, 2021

Financial overview of the second quarter and the half year  Second quarter 2021, April 1 – June 30  · Net sales amounted to KSEK 0 (0). · Result after taxes amounted to KSEK -6 619 (-4 202). · Earnings per share before and after dilution amounted to SEK -0.08 (-0.06). · Cash flow from operating activities after changes in working capital amounted to KSEK -8 546 (-2 541). First half year 2021, January 1 – June 30  · Net sales amounted to KSEK 0 (0). · Result after taxes amounted to KSEK -13 444 (-6 997). · Earnings per share before and after dilution amounted

NORDEN ON TRACK FOR BEST ANNUAL RESULT IN 11 YEARS AND INCREASES GUIDANCE FOR FULL-YEAR RESULT

ANNOUNCEMENT NO. 72 - 18 AUGUST 2021 For the second quarter 2021, NORDEN reports an adjusted result of USD 32 million - the best quarterly result in six years, and is on track to deliver its best annual result in 11 years. NORDEN has capitalised on the incredibly strong dry cargo market during Q2, thanks to record-high exposure, ongoing positioning and the ability to generate margins through strong operator activity. In addition, NORDEN has benefitted from significant increases in the market value of owned and leased vessels in the Asset Management unit, rising by USD 258 million

Transactions in connection with share buy-back programme

On 4 March 2021, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). On 18 March 2021, the share buy-back programme was increased by DKK 15 million, thereby increasing the maximum aggregate purchase price of the shares to be bought back under the programme to DKK 115 million. The share buy-back

Metso Outotec launches the game-changing, compact Elution and Goldroom plant

Metso Outotec Corporation press release, August 18, 2021 at 09:00 am EESTMetso Outotec is introducing the compact Elution and Goldroom plant, a standardized solution for the forming of concentrated eluate to be processed for gold recovery by electrowinning. The innovative plant design is based on pre-engineered modules to reduce engineering, delivery, and construction, as well as commissioning time and investment cost. It also provides the flexibility needed to meet the various process, layout, and regulatory requirements. “The launch of the Metso Outotec Elution and Goldroom plant is an

Fuud recruits Country Manager in Norway

STOCKHOLM, 18 Aug, 2021 08.00 CEST Fuud continues its Nordic expansion in Functional Foods and appoints Björn Alvaer as Country Manager in Norway.Fuud, which in the spring made five acquisitions in the fast-growing food category Functional Foods, continues its expansion in the Nordic region by recruiting Björn Alvaer as Country Manager. Björn has many years of experience in the food industry and has worked in retail for Coca-Cola, Kraft Foods/Mondelez and Findus. Björn Alvaer, Country Manager Norway comments: · In a short time, Fuud has built up an exciting company with a strong

Alligator Bioscience announces Immuno-oncology Research Collaboration and License Agreement with Orion Corporation

Alligator Bioscience (Nasdaq Stockholm: ATORX) announced today that the company has entered into a research collaboration and license agreement with Orion Corporation, a global pharmaceutical company based in Finland, to discover and develop together new bispecific antibody cancer therapeuticsThe research collaboration will focus on the discovery of novel bispecific antibodies directed towards immuno-oncology targets selected by Orion. The agreement covers an option to develop three bispecific antibodies. Under the agreement, Alligator Bioscience will employ its proprietary phage display

Towards smarter buildings – pilots put innovation in the construction industry into practice

YIT Corporation News 18 August 2021 at 09:00 a.m.Construction may appear to be a traditional industry, but many construction projects are constantly being designed and implemented to test new innovations and digital solutions that drive the industry forward. As a major operator and developer, YIT is often a key player in pilot projects combining and integrating the needs of different stakeholders. A random passer-by may not notice that new innovations and operating models are being tested on regular-looking construction sites today. YIT provides a favourable framework for many of these

Ranplan partners with Chongqing College of Electronic Engineering

Stockholm, Sweden, 18 August 2021 – Following a comprehensive evaluation in the last few months, Chongqing College of Electronic Engineering (CQCEE) - one of the leading technical institutions in China - has awarded Ranplan Wireless a contract worth around USD 140k (SEK 1.2 million) for the provision of software licenses, training and support over a three-year period. Deliveries of the software resulting in net sales are envisaged to take place in the second half of the 2021 calendar. “We take considerable pride in our contribution and involvement in the advancement of using software

Phuket Sandbox Extension - ”7+7” island hop extension to “Phuket Sandbox” now in effect

The Phuket Sandbox reopening scheme, the so-called “Phuket Sandbox 7+7 Extension” has been approved by Thailand's Centre for COVID-19 Situation Administration (CCSA). This allows travellers from overseas who are fully vaccinated against Covid-19 to enter Phuket, stay on the island for seven days, and then travel on a sealed route to specified destinations in Koh Samui, Koh Phangan, Koh Tao, Krabi, Khao Lak and Koh Yao.   Starting from 16 August, 2021, the “Phuket Sandbox 7+7 Extension” programme allows eligible international travellers to reduce the mandatory stay in Phuket from

Interim report January-June 2021: Increased net sales of 628% driven by M&A and organic growth of 95% and positive EBITDA in Q2.

Name change to BICO Group AB (publ)  The company changed its name per August 12, 2021, from CELLINK AB (publ) to BICO Group AB (publ). The company’s ticker is BICO and the first trading day with the new ticker was on Monday, August 16, 2021. The company’s ISIN code and Order book ID are unchanged. This is an administrative matter and shareholders do not need to take any action. Second quarter: April-June 2021 · Net sales amounted to MSEK 293.1 (40.2), which corresponds to an increase of 628% (36) compared to the corresponding period previous year, of which 95% (8) was organic

Starbreeze AB (publ) Interim report Q2 2021

Second quarter 2021 · Net sales amounted to SEK 32.0 million (31.3). PAYDAY accounted for SEK 31.5 million (28.1). · EBITDA* amounted to SEK -51.8 million (15.5). · EBITDA**, adjusted for one-off effects related to PAYDAY Crime War license agreement, EBITDA amounted to SEK 16.8 million (15.5). · Amortization, depreciation and impairments amounted to SEK 15.5 million (10.6). · Profit before tax was SEK -80.0 million (-8.6). · Basic and diluted earnings per share were SEK -0.11 (-0.02). · The second chapter of PAYDAY 2: City of Gold was successfully launched during the

Interim report, January–June 2021

New orders pave the way for next stepJanuary–June 2021 · Revenue amounted to TSEK 70,346 (94,559) · Operating profit amounted to TSEK -61,568 (-11,958) · Profit after tax amounted to TSEK -49,792 (-18,186). The result includes currency conversions and financial transaction costs of TSEK 11,948 (-9,147) · Earnings per share amounted to SEK -1.08 (-0.51) April–June 2021 · Revenue amounted to TSEK 33,216 (34,983) · Operating profit amounted to TSEK -30,910 (-17,313) · Profit after tax amounted to TSEK -38,538 (-51,891). The result includes currency conversions costs

Inzile adapts and focuses the organization

The electric vehicle manufacturer Inzile is adapting the size of the organization. The Board and management have made the assessment that a reduction in costs is necessary to make Inzile a profitable and successful growth company. The size of the organization will be adapted to the current sales level and includes both the company's management and other staff. Negotiations with trade unions have been initiated regarding blue- and white-collar employees.  - I have now had the opportunity to familiarize myself with Inzile and analyze the company's opportunities. We have set a new sales

Prostatype Genomics presents Interim Report for the period 1 April to 30 June 2021

- Prostatype Genomics presents Quarterly report for the second quarter of 2021. The Report is available on the Company's home page.Quarter 2 (1 April – 30 June 2021) summarized · Net sales amounted to 549 TSEK. · Net revenue amounted to 5 TSEK. · EBITDA (earnings before interest, taxes, depreciation, and amortization) amounted to -2 373 TSEK. · Cash flow from current operations in the quarter amounted -2 353 TSEK. · Total cash flow for the period amounted to -2 862 TSEK. · Earnings per share amounted to -0,18 SEK.  Significant events during the Second Quarter ·

Investor Report

Regulatory Announcement     Royal Bank of Canada August 18, 2021   RBC Covered Bond Programme Monthly Investor Report   The RBC Covered Bond Programme Monthly Investor Report has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism   To view the full document, please paste the following URL into the address bar of your browser.   RBC Covered Bond Programme Monthly Investor Report dated July 30, 2021 http://www.rns-pdf.londonstockexchange.com/rns/9605I_1-

ASSA ABLOY acquires Omni-ID in the US

ASSA ABLOY has acquired Omni-ID, a leading manufacturer of RFID tags and industrial IoT hardware devices for passive and active tagging, tracking, monitoring and alerting applications, based in the US. "I am very pleased to welcome Omni-ID into the ASSA ABLOY Group. Omni-ID is a strategic technological addition to the ASSA ABLOY Group and reinforces our current RFID and IoT offering and provides complementary growth opportunities,” says Nico Delvaux, President and CEO of ASSA ABLOY. “In addition to broadening our value-added RFID components and active identification devices offering,

Miimu Airaksinen appointed SVP, Development and Antti Nummi SVP, Commercial in SRV Group Plc

SRV GROUP PLC     STOCK EXCHANGE RELEASE     18 AUGUST 2021       9:00 EET Miimu Airaksinen appointed SVP, Development and Antti Nummi SVP, Commercial in SRV Group Plc Miimu Airaksinen, D.Sc. (Tech.), 48, has been appointed SVP, Development, and a member of Corporate Executive Team of SRV Group Plc as of 2 September 2021. SRV Group Plc’s SVP, Business Development, Antti Nummi, M.Sc. (Soc.), 49, has been appointed SVP, Commercial as of 2 September 2021. He continues as a member of Corporate Executive Team of SRV Group Plc. The appointments strengthen the implementation of SRV’s

OssDsign AB (publ) publishes Q2 2021 Interim Report

Continued sales growth despite ongoing COVID-19 pandemicThe second quarter in figures · Net sales amounted to TSEK 7,643 (3,905) · Loss after taxes amounted to TSEK 25,332 (22,586) · Earnings per share was SEK -0.4 (-1.3) · Cash flow from current operations was TSEK -11,169 (-15,829) The first half year in figures · Net sales amounted to TSEK 13,629 (11,631) · Loss after taxes amounted to TSEK 48,661 (40,898) · Earnings per share was SEK -1,2 (-2.3) · Cash flow from current operations was TSEK -34,503 (-37,962) Important Events during the second quarter

Gaming Innovation Group reports Q2 2021

Gaming Innovation Group Inc. (GiG) reports Q2 2021 revenues* of €16.2 million and an EBITDA of €5.3 million.  “Another rewarding quarter for GiG, with meaningful growth in revenues, EBITDA and EBIT as well as underlying business dynamics. The Company is progressing towards our business growth & expansion strategies, improving delivery and future position of the group”, says Richard Brown, CEO of GiG.  Financial Highlights · Revenues* in Q2 2021 were €16.2m (13.2), an increase of 23%, all organic growth · EBITDA was €5.3m (2.8), up 86%, EBITDA margin* increased to 32.6% (21.6%)

There are no items matching the current filter
There are no more items matching the current filter
Back to top